Methoxamine: Difference between revisions

	WikiDoc Resources for Methoxamine
Articles
Most recent articles on Methoxamine Most cited articles on Methoxamine Review articles on Methoxamine Articles on Methoxamine in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Methoxamine Images of Methoxamine Photos of Methoxamine Podcasts & MP3s on Methoxamine Videos on Methoxamine
Evidence Based Medicine
Cochrane Collaboration on Methoxamine Bandolier on Methoxamine TRIP on Methoxamine
Clinical Trials
Ongoing Trials on Methoxamine at Clinical Trials.gov Trial results on Methoxamine Clinical Trials on Methoxamine at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Methoxamine NICE Guidance on Methoxamine NHS PRODIGY Guidance FDA on Methoxamine CDC on Methoxamine
Books
Books on Methoxamine
News
Methoxamine in the news Be alerted to news on Methoxamine News trends on Methoxamine
Commentary
Blogs on Methoxamine
Definitions
Definitions of Methoxamine
Patient Resources / Community
Patient resources on Methoxamine Discussion groups on Methoxamine Patient Handouts on Methoxamine Directions to Hospitals Treating Methoxamine Risk calculators and risk factors for Methoxamine
Healthcare Provider Resources
Symptoms of Methoxamine Causes & Risk Factors for Methoxamine Diagnostic studies for Methoxamine Treatment of Methoxamine
Continuing Medical Education (CME)
CME Programs on Methoxamine
International
Methoxamine en Espanol Methoxamine en Francais
Business
Methoxamine in the Marketplace Patents on Methoxamine
Experimental / Informatics
List of terms related to Methoxamine

Methoxamine
Clinical data
ATC code	C01CA10 (WHO) ;
Identifiers
CAS Number	390-28-3;
PubChem CID	6082;
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C11H17NO3
Molar mass	211.258

VisualWikitext

Latest revision as of 00:05, 24 July 2014

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Methoxamine is an α₁-adrenergic receptor agonist,^[1] similar in structure to phenylephrine and 2,5-DMA. It was developed by Burroughs-Wellcome in the 1940s.^[2] The drug induces vasoconstriction of skin and splanchnic blood vessels, thereby increasing peripheral vascular resistance and raising mean arterial blood pressure. Because of its hypertensive effects, it may evoke a compensatory reflex bradycardia via the baroreceptors.

References

↑ Pazdernik, Thomas L.; Kerecsen, Laszlo (2007) [2003]. "5". In Goljan, Edward F. Pharmacology (Paperback)|format= requires |url= (help). Rapid Review (Second ed.). Philadelphia, PA: Mosby-Elsevier. p. 39. ISBN 978-0-323-04550-6. |access-date= requires |url= (help)
↑ US Patent 2359707 - DIMETHOXYPHENYL beta-HYDROXY ISOPROPYLAMINE

Template:Stimulants Template:Cardiac stimulants excluding cardiac glycosides Template:Phenethylamines

[1] Pazdernik, Thomas L.; Kerecsen, Laszlo (2007) [2003]. "5". In Goljan, Edward F. Pharmacology (Paperback)|format= requires |url= (help). Rapid Review (Second ed.). Philadelphia, PA: Mosby-Elsevier. p. 39. ISBN 978-0-323-04550-6. |access-date= requires |url= (help)

[2] US Patent 2359707 - DIMETHOXYPHENYL beta-HYDROXY ISOPROPYLAMINE

[1]

[2]

@@ Line 25: / Line 25: @@
 | routes_of_administration =
 }}
+__NOTOC__
+{{SI}}
 {{CMG}}
-{{Editor Join}}
+==Overview==
+'''Methoxamine''' is an α<sub>1</sub>-[[adrenergic agonist|adrenergic receptor agonist]],<ref>{{cite book |last1=Pazdernik |first1=Thomas L. |authorlink1= |last2=Kerecsen |first2=Laszlo |editor1-first=Edward F. |editor1-last=Goljan |editor1-link= |others= |title=Pharmacology |trans_title= |url= |format=Paperback |accessdate=17 Apr 2010 |type= |edition=Second |series=Rapid Review |volume= |date= |year=2007 |month= |origyear=2003|publisher=Mosby-Elsevier |location=Philadelphia, PA |isbn=978-0-323-04550-6 |oclc= |doi= |id= |page=39 |pages= |trans_chapter= |chapter=5 |chapterurl= |quote= |ref= |bibcode= |laysummary= |laydate= |separator= |postscript= |lastauthoramp=}}</ref> similar in structure to [[phenylephrine]] and [[2,5-DMA]]. It was developed by Burroughs-Wellcome in the 1940s.<ref>US Patent 2359707 - DIMETHOXYPHENYL beta-HYDROXY ISOPROPYLAMINE</ref> The drug induces vasoconstriction of skin and [[splanchnic]] blood vessels, thereby increasing peripheral vascular resistance and raising mean arterial blood pressure. Because of its hypertensive effects, it may evoke a compensatory reflex [[bradycardia]] via the [[baroreceptors]].
-==Overview==
+== See Also ==
-'''Methoxamine''' is an α<sub>1</sub>-[[adrenergic agonist|adrenergic receptor agonist]], similar to [[phenylephrine]]. It induces vasoconstriction of skin and [[splanchnic]] blood vessels, thereby increasing peripheral vascular resistance and raising mean arterial blood pressure. Because of its hypertensive effects, it may evoke a compensatory reflex [[bradycardia]].
+* [[Butaxamine]]
+* [[Phenylephrine]]
+* [[Synephrine]]
+== References ==
+{{Reflist|2}}
+{{Stimulants}}
 {{Cardiac stimulants excluding cardiac glycosides}}
+{{Phenethylamines}}
-[[Category:Phenethylamines]]
+[[Category:Amphetamines]]
-[[Category:Drugs]]
+[[Category:Cardiovascular Drugs]]
+[[Category:Drug]]
-{{WikiDoc Help Menu}}
-{{WikiDoc Sources}}

Clinical data

ATC code	C01CA10 (WHO)
Identifiers
CAS Number	390-28-3
PubChem CID	6082
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C₁₁H₁₇NO₃
Molar mass	211.258

Methoxamine: Difference between revisions

Latest revision as of 00:05, 24 July 2014

Overview

See Also

References

Navigation menu